Expert Testimony Excluded on Link Between Gadolinium MRI Contrast Agents and Health Problems Claimed in Lawsuits
A federal judge has dismissed plaintiff experts who were key to proving that gadolinium deposition can cause a host of health problems.
A federal judge has dismissed plaintiff experts who were key to proving that gadolinium deposition can cause a host of health problems.
A new study links repeated use of Omniscan with gadolinium deposition in MS patients.
A new study finds that older, linear gadolinium contrast agents appear to have a much higher risk of leaving behind high levels of gadolinium in the brain.
A gadolinium exposure lawsuit claims that IV injections of various MRI contrast dyes caused severe injury due to an allergic reaction.
Changes in children's brains may make them more susceptible to gadolinium retention after the age of two, according to the findings of a new study.
A gadolinium retention lawsuit says Multihance, Magnevist and Omniscan MRI contrast dyes are defective, resulting in injury from toxic chemicals.
A new study indicates that linear gadolinium contrast dyes leave deposits of the chemical in rat brains for at least a year.
A MRI contrast agent lawsuit claims multiple injections of Omniscan and Multihance resulted in gadolinium deposition disease.
Growing evidence suggests some types of MRI contrast dyes may be more prone to leave behind traces of gadolinium in the human body.
A new study warns that chelation does not appear to be effective in removing gadolinium from the body.